News

Agency claims union would threaten a monopoly on programmatic advertising space.

The debut will be the CDMO’s first fully automated sterile injectable manufacturing line at the Wuxi, China site.

Report reiterates CDMO’s commitment to net-zero emissions.

Annual industry seminar will help address compliance obstacles, as the DSCSA deadline approaches.

Demand comes among antitrust agency’s recent denial of Amgen’s Horizon buyout.

Goal of the deal is to boost the production of oral dosage forms.

The 50,000 square-foot facility will feature 10 new manufacturing sites with commercial capabilities.

Recent data and commentary offer insights into how biologics vs. small molecule patent protections under the Inflation Reduction Act pricing scenarios is impacting investing in the biotech sector.

Ruling validates antitrust theory, pushes antitrust arbitration against Prime Therapeutics forward.

April 2023 numbers include the privately insured, such as Medicare Advantage.

Award honors rxfel’s use of best practices in preserving customer data.

Medicare-eligible patients need to be enrolled in registry to get Medicare coverage for the anti-beta amyloid drug that is priced to cost $26,500 a year.

Nonetheless, capacity is up nearly 6% above pre-pandemic levels.

AmerisourceBergen’s new 34,000 square-foot plant in Chicago area will support shipments that require temperature storage/delivery as cold as cryogenic.

The National Alliance of Healthcare Purchaser Coalitions releases resources for employers/health plan purchasers to offer insights on PBMs role in high prescription drug costs.

New CSafe product, expected early next year, features a -20°C setpoint.

Healthcare stakeholders suggest system changes, proving therapeutic value.

Platform is expected to streamline the label management process.

Union adds to company’s goal of reaching net-zero emissions by 2045.

Pharma company will produce seven vaccines, as nation aims to strengthen status as a life sciences hub.

EMA, the European Commission, and HMAs are phasing out the flexible regulations put into place during the pandemic.

Executive succeeds Ken Paulus as head of the PBM.

Recent lawsuits are challenging the constitutionality of provisions in the Inflation Reduction Act.

Agreement is expected to help improve the medication delivery process for patients.

New solution is expected to focus on products’ time and temperature-sensitive requirements.

The latest people news happenings over the past month.

Software allows pharmacies to meet legislation’s upcoming Nov. 27 deadline.

The 26,000 square-foot plant with further expand the company’s temperature-controlled services.